Increased production of prostaglandin D2 in patients with systemic mastocytosis. Roberts LJ, Sweetman BJ, Lewis RA, Austen KF, Oates JA (1980) N Engl J Med 303: 1400-4 Intervention with epinephrine in hypotension associated with mastocytosis. Turk J, Oates JA, Roberts LJ (1983) J Allergy Clin Immunol 71: 189-92 Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. Awad JA, Morrow JD, Roberts LJ (1994) J Allergy Clin Immunol 93: 817-24 Recurrent syncope due to systemic mastocytosis. Roberts LJ (1984) Hypertension 6: 285-94 Hazards in operative management of patients with systemic mastocytosis. Scott HW, Parris WC, Sandidge PC, Oates JA, Roberts LJ (1983) Ann Surg 197: 507-14 Increased formation of thromboxane in vivo in humans with mastocytosis. Morrow JD, Oates JA, Roberts LJ, Zackert WE, Mitchell TA, Lazarus G, Guzzo C (1999) J Invest Dermatol 113: 93-7 Urticaria pigmentosa and natural sunlight. Vire G, Roberts LJ, King LE (1986) J Am Acad Dermatol 14: 687-8 Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Guzzo C, Lavker R, Roberts LJ, Fox K, Schechter N, Lazarus G (1991) Arch Dermatol 127: 191-6 Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. Liston TE, Roberts LJ (1985) J Biol Chem 260: 13172-80 The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. Kootte AM, Haak A, Roberts LJ (1983) Neth J Med 26: 18-20 Quantification of the PGD2 urinary metabolite 9 alpha-hydroxy-11, 15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid by stable isotope dilution mass spectrometric assay. Roberts LJ (1982) Methods Enzymol 86: 559-70
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.